Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Microbiol. 2008 Dec;16(12):574-9. doi: 10.1016/j.tim.2008.08.012. Epub 2008 Oct 27.

The (political) economics of antiretroviral treatment in developing countries.

Author information

  • 1AIDS and Society Research Unit, University of Cape Town, Private Bag, Rondebosc, Cape Town 7701, South Africa. nicoli.nattrass@gmail.com

Abstract

Despite unprecedented international mobilisation to support universal provision of highly active antiretroviral therapy (HAART), national governments continue to play the key role in determining access to treatment. Whereas some AIDS-affected countries have performed as well as or better than expected given their level of development, institutional characteristics and demographic challenges (e.g. Thailand and Brazil), others (notably South Africa) have not. This article argues that the 'economics' of antiretroviral drug delivery is at heart a political-economy of access to treatment. It depends on commitment on the part of national governments to negotiate with pharmaceutical companies over patented antiretroviral drug prices, on their policy towards compulsory licensing, and on the approach they adopt to delivering HAART. Civil society has an important role to play in encouraging governments to become, and remain, committed to taking action to ensure sustainable and widespread access to HAART.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk